Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Antibodies against programmed death-1 (PD-1), and its ligand, (PD-L1) have been approved recently for the treatment of small-cell lung cancer (SCLC). Although there are previous reports that addressed PD-L1 detection on tumour cells in SCLC, there is no comprehensive meta-analysis on the prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales: Acheampong, Emmanuel, Abed, Afaf, Morici, Michael, Bowyer, Samantha, Amanuel, Benhur, Lin, Weitao, Millward, Michael, S. Gray, Elin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693331/
https://www.ncbi.nlm.nih.gov/pubmed/33142852
http://dx.doi.org/10.3390/cells9112393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693331/
https://www.ncbi.nlm.nih.gov/pubmed/33142852
http://dx.doi.org/10.3390/cells9112393

Ejemplares similares